In the present study, we elucidated a novel mechanism by which disorganisation of HACE1–cyclin C interaction drives gastric cancer cell resistance to cisplatin treatment by deregulating mitochondrial‐associated oxidative stress. The gene discussed is HACE1; the disease is gastric cancer.